HALO: Record revenues and expanding subQ pipeline drive strong growth and future royalty streams
Record revenue growth driven by ENHANZE and new subcutaneous launches, with expanding pipeline and five new deals supporting future royalties. SubQ delivery is now a commercial mandate, and HyperCon technology is advancing with robust partner interest. Capital allocation remains disciplined, balanc…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.